OptiNose Valuation
| OPTNDelisted Stock | USD 9.60 0.07 0.72% |
At this time, the company appears to be overvalued. OptiNose holds a recent Real Value of $7.26 per share. The prevailing price of the company is $9.6. Our model determines the value of OptiNose from analyzing the company fundamentals such as Shares Outstanding of 10.13 M, return on equity of -10.5, and Operating Margin of (0.41) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that OptiNose's price fluctuation is very steady at this time. Calculation of the real value of OptiNose is based on 3 months time horizon. Increasing OptiNose's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since OptiNose is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OptiNose Stock. However, OptiNose's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.6 | Real 7.26 | Hype 9.6 |
The intrinsic value of OptiNose's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence OptiNose's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of OptiNose helps investors to forecast how OptiNose stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OptiNose more accurately as focusing exclusively on OptiNose's fundamentals will not take into account other important factors: About OptiNose Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of OptiNose. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of OptiNose based exclusively on its fundamental and basic technical indicators. By analyzing OptiNose's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of OptiNose's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of OptiNose. We calculate exposure to OptiNose's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of OptiNose's related companies.OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. Optinose operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 189 people.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in OptiNose Stock
If you are still planning to invest in OptiNose check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OptiNose's history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |